FeaturedImmunology
Sparsentan (Filspari)
Travere Therapeutics
Dual endothelin/angiotensin receptor antagonist. FDA approved in IgAN. PROTECT Phase 3 confirmatory eGFR data ongoing.
IgA Nephropathy
Loading comments…
Also Known As
Other names
sparsentan